Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Andrea S. Lukes"'
Autor:
Gary R. Eldridge, Heidi Hughey, Lois Rosenberger, Steven M. Martin, Andrew Marc Shapiro, Elizabeth D’Antonio, Kent G. Krejci, Neal Shore, James Peterson, Andrea S. Lukes, Courtney M. Starks
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 5, Pp 1262-1270 (2021)
Antibiotic resistance among gram-negative bacteria continues to rise globally at an alarming rate. New vaccines that prevent bacterial infections and reduce antibiotic use could provide a potential solution to these problems. This study focused on de
Externí odkaz:
https://doaj.org/article/97940187c7234a63a0394e6d90da40b3
Autor:
Ayman Al-Hendy, Andrea S. Lukes, Alfred N. Poindexter, Roberta Venturella, Claudio Villarroel, Laura McKain, Yulan Li, Rachel B. Wagman, Elizabeth A. Stewart
Publikováno v:
Obstetrics & Gynecology. 140:920-930
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b29818eb31f4a1a63e6f71fba7b7cbe4
https://doi.org/10.1097/aog.0000000000004988
https://doi.org/10.1097/aog.0000000000004988
Autor:
Ayman Al-Hendy, Andrea S Lukes, Alfred N Poindexter, Roberta Venturella, Claudio Villarroel, Hilary OD Critchley, Yulan Li, Laura McKain, Juan C Arjona Ferreira, Andria GM Langenberg, Rachel B Wagman, Elizabeth A Stewart
Publikováno v:
Pain Management.
What is this summary about? This is a summary of research studies (known as clinical trials) called LIBERTY 1 and LIBERTY 2. The LIBERTY 1 and LIBERTY 2 studies looked at how well a medication called relugolix combination therapy worked to reduce hea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d59d24885a11133e79ddb224aed2915
https://doi.org/10.2217/pmt-2022-0085
https://doi.org/10.2217/pmt-2022-0085
Relugolix Combination Therapy for Uterine Leiomyoma–Associated Pain in the LIBERTY Randomized Trials
Autor:
Elizabeth A, Stewart, Andrea S, Lukes, Roberta, Venturella, Juan-Camilo, Arjona Ferreira, Yulan, Li, Elke, Hunsche, Rachel B, Wagman, Ayman, Al-Hendy
Publikováno v:
Obstetrics & Gynecology. 139:1070-1081
To assess the effect of once-daily relugolix combination therapy (relugolix-CT: relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg) compared with placebo on moderate-to-severe pain in women with uterine leiomyomas and heavy menstrual b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd2b3f6425d5abc72e4d05684cf62f30
https://doi.org/10.1097/aog.0000000000004787
https://doi.org/10.1097/aog.0000000000004787
Autor:
Gary R. Eldridge, Andrew Marc Shapiro, Lois Rosenberger, James Peterson, Neal Shore, Steven M. Martin, Andrea S. Lukes, Kent G. Krejci, Heidi Hughey, Elizabeth D’Antonio, Courtney M. Starks
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Antibiotic resistance among gram-negative bacteria continues to rise globally at an alarming rate. New vaccines that prevent bacterial infections and reduce antibiotic use could provide a potential solution to these problems. This study focused on de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd5a57afd46cd41a8cf0212d72f01171
https://doi.org/10.1080/21645515.2020.1834807
https://doi.org/10.1080/21645515.2020.1834807
Autor:
Sawsan As-Sanie, Neil Johnson, Andrea S. Lukes, Juan Camilo Arjona Ferreira, Juliet Li, Julie Stein Perry, Rachel B. Wagman, Linda C. Giudice
Publikováno v:
Fertility and Sterility. 118:e6-e7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3d9ac66613df841bb59143a4323c0ff
https://doi.org/10.1016/j.fertnstert.2022.08.035
https://doi.org/10.1016/j.fertnstert.2022.08.035
Autor:
Elizabeth A. Stewart, Andrea S. Lukes, Roberta Venturella, Yulan Li, Elke Hunsche, Rachel B. Wagman, Ayman Al-Hendy
Publikováno v:
American journal of obstetrics and gynecology.
Symptomatic uterine fibroids are burdensome to live with; they are associated with symptom-related distress, affect daily activities, and reduce health-related quality of life. The LIBERTY randomized clinical trials showed that oral relugolix combina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcf0adfca67d7fc8e49c2000d61cce14
https://pubmed.ncbi.nlm.nih.gov/36370871
https://pubmed.ncbi.nlm.nih.gov/36370871
Autor:
Minda A Green, Andrea S. Lukes
Publikováno v:
Journal of Gynecologic Surgery
Objective: This article reports on 3-year clinical outcomes of the Sonography Guided Transcervical Ablation of Uterine Fibroids (SONATA) pivotal trial of transcervical fibroid ablation (TFA) in women with symptomatic uterine myomata. Materials and Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7aa308b8be8dbf62f055a13c5606b9ab
http://europepmc.org/articles/PMC7548023
http://europepmc.org/articles/PMC7548023
Autor:
Andrea S. Lukes, Ayman Al-Hendy, R. B. Wagman, Y. Li, Elizabeth A. Stewart, Felice Petraglia, Roberta Venturella, W Decleer, Elke Hunsche, T Nyirady
Publikováno v:
Human Reproduction. 36
Study question What is the effect of relugolix combination therapy (Relugolix-CT) on symptom burden and health-related quality-of-life (HR-QoL) in patients with uterine fibroids (UF) over 52 weeks? Summary answer Relugolix-CT demonstrated sustained,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85c176e583365cf568161fb0675adc64
https://doi.org/10.1093/humrep/deab126.061
https://doi.org/10.1093/humrep/deab126.061
Publikováno v:
International Journal of Women's Health. 11:387-394
Objective The prospective SONATA pivotal Investigational Device Exemption (IDE) trial was performed in the United States (US) and Mexico to examine the safety and effectiveness of transcervical fibroid ablation (TFA) in the treatment of symptomatic u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::625f3d142b2959a11e3baf3fedf107ed
https://doi.org/10.2147/ijwh.s201912
https://doi.org/10.2147/ijwh.s201912